Compounded Tirzepatide (Injectable) has not been evaluated by the FDA, but side effects are expected to be similar to other Tirzepatide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Foods, like cruciferous vegetables, garlic, and onions can also boost glutathione levels for better detoxification
However, significant results typically appear after 12 weeks or more, especially when the injection is taken with a reduced-calorie diet plan and regular exercise as directed by a doctor
Compounding pharmacies will sometimes repackage these drugs, or create lower or different concentrations than whats typically available
While not medical advice, these voices highlight the diversity of patient experiences - and the way GLP-1 medicines ripple through the body beyond appetite and digestion
Generic manufacturers must conduct bioequivalence studies proving their version works identically to the brand-name product, submit these studies to the FDA for approval (a process taking months to years), and then begin manufacturing and distribution